← Back to Search

Dietary Supplement

Oxidative Stress for Chronic Pain

Phase 2
Recruiting
Led By Joshua Gunn, PhD
Research Sponsored by Ethos Research & Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Seeking treatment for chronic pain as defined as symptoms persisting for ≥ 3 months
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month of supplementation, 3 months and at 3 month follow up.
Awards & highlights

Study Summary

This trial aims to study how daily nutritional supplements, tailored to individual urine biomarkers, can improve the quality of life and pain levels in patients with chronic pain. Participants will be given supplements based on their

Who is the study for?
This clinical trial is for individuals suffering from chronic pain. Participants will be selected based on specific markers in their urine that indicate deficiencies related to their condition. The study excludes details not provided.Check my eligibility
What is being tested?
The study tests the effects of three dietary supplements designed to support inflammation, nerve health, and redox balance based on individual urinary biomarkers. It aims to improve quality of life over a 3-month period by tailoring supplementation to each person's needs.See study design
What are the potential side effects?
Potential side effects are not detailed in the information provided but may include reactions typical of dietary supplements such as digestive discomfort or allergic responses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been experiencing chronic pain for 3 months or more.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 2 months, 3 months and at 3 month follow up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 2 months, 3 months and at 3 month follow up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality-of-life measures.
Quantitative urine biomarker levels.
Secondary outcome measures
Anxiety symptoms.
Depression symptoms.
Profile of Mood States
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Oxidative StressExperimental Treatment1 Intervention
Group II: Nerve HealthExperimental Treatment1 Intervention
Group III: InflammationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Ethos Research & DevelopmentLead Sponsor
2 Previous Clinical Trials
50 Total Patients Enrolled
2 Trials studying Chronic Pain
50 Patients Enrolled for Chronic Pain
Joshua Gunn, PhDPrincipal InvestigatorEthos Research and Development
~50 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top